Account
Havas Media Group India retains MTS India account
MUMBAI: Havas Media Group India has yet again retained MTS India’s integrated media business following a multi agency pitch which included all the top agencies.
Speaking on the retention, MTS India chief marketing and sales officer Leonid Musatov said, “Havas has been our partner since we launched in this country. Their thought leadership, digital-at-the-core approach and category understanding was impressive. Considering all such attributes, we have decided to retain Havas as our partner agency.”
“Given MTS India’s data centric play within the telecom industry we wanted to extend our digital focus. After considering various options, we have decided to retain Havas Media as our agency. We look forward to working with the Havas team with renewed vigour,” added MTS India brand and media director Amitesh Rao.
Havas Media Group India and south Asia CEO Anita Nayyar said, “It is a matter pride that MTS has once again chosen Havas Media. The pitch has further entrenched our relationship with MTS. It has been a great association till now and we will ensure we provide more meaningful connections for the brand in the coming year.”
“MTS is a dynamic brand which thrives on innovation. We are very confident that we will keep up the great work that we have been doing over the years for the brand. We are delighted to be extending our partnership with them,” commented Havas Media India MD Mohit Joshi.
Havas Media recently won the integrated media mandate of Yepme.com and the digital duties of XOLO mobile and Business World.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
